Versantis
is a biotechnology company that develops and commercializes therapies for the treatment of liver and pediatric diseases... Read moreVersantis
is a biotechnology company that develops and commercializes therapies for the treatment of liver and pediatric diseases... Read more
News
Dec 20, 2021
MarketScreener
Versantis: Versantis Appoints Mark Fitzpatrick, Seasoned Biotech Executive, as its New CEO
Dec 20, 2021
firstword pharma
Versantis: Versantis Appoints Mark Fitzpatrick as its New CEO
Nov 15, 2021
MarketScreener
Versantis: Versantis to Present Positive Phase 1b Data at AASLD for VS-01 in Patients with Decompensated Cirrhosis
Sep 07, 2021
MarketScreener
Versantis: Versantis : Receives U.S. FDA Orphan Drug Designation for VS-01
Mar 18, 2021
Clinical Trials Arena
Versantis: Versantis reports positive data from decompensated liver cirrhosis study
Mar 17, 2021
FinanzNachrichten
Versantis: Versantis Announces Positive Phase 1b Results for VS-01 in Patients with Decompensated Cirrhosis
Mar 17, 2021
startupticker
Versantis: Versantis celebrates successful first-in-human trial
Mar 11, 2021
startupticker ch
Versantis: New appointments at life sciences startups
Feb 05, 2021
MarketScreener
Versantis: Versantis Appoints Seasoned Pharma Executive Christopher Seaton to Board
Oct 20, 2020
Pharmaceutical Business Review
Versantis: Versantis receives FDA rare paediatric disease designation for VS-01 to treat urea cycle disorders
Versantis Competitors
1
2
3
4
5
6
7
8
9
10